Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|August 31, 2015
Susceptibility testing challenges with ceftaroline, MRSA and a 1 mg/L breakpointDavid M Livermore, Shazad Mushtaq, Marina Warner, et al.
Antimicrobial Agents and Chemotherapy|January 11, 2007
In vitro activity of the oxazolidinone RWJ-416457 against linezolid-resistant and -susceptible staphylococci and enterococciDavid M Livermore, Marina Warner, Shazad Mushtaq, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2017
In vitro activity of cefepime/zidebactam (WCK 5222) against Gram-negative bacteriaDavid M Livermore, Shazad Mushtaq, Marina Warner, et al.
The Journal of Antimicrobial Chemotherapy|June 6, 2007
In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypesShazad Mushtaq, Marina Warner, Yigong Ge, et al.
The Journal of Antimicrobial Chemotherapy|June 22, 2010
Performance of the Oxoid M.I.C.Evaluator Strips compared with the Etest assay and BSAC agar dilutionShazad Mushtaq, Marina Warner, Jonathan Cloke, et al.
The Journal of Antimicrobial Chemotherapy|October 24, 2017
Potential of high-dose cefepime/tazobactam against multiresistant Gram-negative pathogensDavid M Livermore, Shazad Mushtaq, Marina Warner, et al.
The Journal of Antimicrobial Chemotherapy|November 6, 2009
Polyclonal multiply antibiotic-resistant methicillin-resistant Staphylococcus aureus with Panton-Valentine leucocidin in EnglandMatthew J Ellington, Mark Ganner, Marina Warner, et al.
The Journal of Antimicrobial Chemotherapy|March 24, 2012
Characterization of β-lactamase and porin mutants of Enterobacteriaceae selected with ceftaroline + avibactam (NXL104)David M Livermore, Shazad Mushtaq, Kevin Barker, et al.
The Journal of Antimicrobial Chemotherapy|July 5, 2015
Pathogens of skin and skin-structure infections in the UK and their susceptibility to antibiotics, including ceftarolineDavid M Livermore, Shazad Mushtaq, Marina Warner, et al.
International Journal of Antimicrobial Agents|March 25, 2011
What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecyclineDavid M Livermore, Marina Warner, Shazad Mushtaq, et al.
Pageof 6